SCHEMBL2234390

SCHEMBL2234390

COC(=O)C(O)=CC(=O)c1cccc(C)c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
PARP1 P09874 1/20 0.46
GPR52 Q9Y2T5 1/20 0.46
MAPT P10636 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KCNK3 O14649 3/20 0.44
KCNK9 Q9NPC2 3/20 0.44
POLB P06746 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KCNH2 Q12809 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2234385 1.00 SMN1; SMN2 (0.49) SMN1; SMN2HDAC8HDAC6PARP1GPR52
SCHEMBL933234 0.85 GPR52 (0.47) SMN1; SMN2HDAC8HDAC6PARP1GPR52
SCHEMBL933233 0.85 GPR52 (0.47) SMN1; SMN2HDAC8HDAC6PARP1GPR52
SCHEMBL15563146 0.83 PARP1 (0.52) SMN1; SMN2HDAC8HDAC6PARP1GPR52
SCHEMBL15563147 0.83 PARP1 (0.52) SMN1; SMN2HDAC8HDAC6PARP1GPR52
SCHEMBL3310563 0.83 NFE2L2 (0.53) SMN1; SMN2MAPTALDH1A1POLBMEN1
SCHEMBL2232374 0.83 NFE2L2 (0.53) SMN1; SMN2MAPTALDH1A1POLBMEN1
SCHEMBL2232370 0.83 NFE2L2 (0.53) SMN1; SMN2MAPTALDH1A1POLBMEN1
SCHEMBL2232262 0.83 MAOB (0.57) SMN1; SMN2PARP1GPR52MAPTALDH1A1
SCHEMBL2232266 0.83 MAOB (0.57) SMN1; SMN2PARP1GPR52MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011092505-A1 S100 PROTEIN BINDING INTERACTION INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2011-08-04 WO disclosed